On October 2, 2026 20/20 BioLabs, Inc. (Nasdaq: AIDX) (the "Company"), an early market entrant in AI-powered, laboratory-based blood tests for the early detection and prevention of cancers and chronic diseases, reported that President and Chief Executive Officer Jonathan Cohen and Chief Financial Officer Alan Bergman will participate in the Maxim Growth Summit 2026, being held October 13 and 14, 2026 at the Hard Rock Hotel New York. The Summit’s healthcare program takes place Wednesday, October 14.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Mr. Cohen and Mr. Bergman will hold one-on-one meetings with institutional investors at the Summit and in additional meetings scheduled in New York that week.
Maxim Growth Summit 2026
Dates: October 13 and 14, 2026; healthcare program Wednesday, October 14
Location: Hard Rock Hotel New York, 159 West 48th Street, New York, NY 10036
Format: One-on-one investor meetings
Attendees: President and Chief Executive Officer Jonathan Cohen; Chief Financial Officer Alan Bergman
Conference Website: Click here
To schedule a one-on-one meeting with management at the Maxim Growth Summit or in New York that week, please contact your Maxim Group representative, email [email protected], or call Chris Tyson at (949) 491-8235.
(Press release, 20/20 GeneSystems, OCT 2, 2026, View Source [SID1234671256])